Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation

Haematologica

Volumn 95, Issue 2, 2010, Pages 276-283

  Berro, Mariano ^a   Mayor, Neema P ^a,b   Maldonado Torres, Hazael ^a,b   Cooke, Louise ^a   Kusminsky, Gustavo ^c   Marsh, Steven G E ^a,b   Madrigal, J Alejandro ^a,b   Shaw, Bronwen E ^a,b,d  

^a ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSIDAD AUSTRAL   (Argentina)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Graft versus host disease; Polymorphisms; Stem cell transplantation; Survival; TGF 1

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN A; METHOTREXATE; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER MORTALITY; CANCER RELAPSE; CHRONIC GRAFT VERSUS HOST DISEASE; CODON; CONTROLLED STUDY; DONOR; FEMALE; GENETIC CODE; GENOTYPE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMOZYGOSITY; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; SURVIVAL TIME; WILD TYPE;

ADULT; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 76549092266     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.010835     Document Type: Article

References (37)

1. Petersdorf EW. Risk assessment in haematopoietic stem cell transplantation: histocompatibility. Best Pract Res Clin Haematol. 2007;20(2):155-70.
2. Petersdorf EW, Anasetti C, Martin PJ, Hansen JA. Tissue typing in support of unrelated hematopoietic cell transplantation. Tissue Antigens. 2003;61(1):1-11.
3. Aschan J. Risk assessment in haematopoietic stem cell transplantation: conditioning. Best Pract Res Clin Haematol. 2007;20(2):295-310.
4. Shaw BE, Gooley TA, Malkki M, Madrigal JA, Begovich AB, Horowitz MM, et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood. 2007;110(13):4560-6.
5. Dickinson AM. Risk assessment in haematopoietic stem cell transplantation: pre-transplant patient and donor factors: non-HLA genetics. Best Pract Res Clin Haematol. 2007;20(2):189-207.
6. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med. 2000;342(18):1350-8.
7. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med. 1993;328(22):1592-8.
8. Bommireddy R, Doetschman T. TGFβ1 and Treg cells: alliance for tolerance. Trends Mol Med. 2007;13(11):492-501.
9. Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 2007; 26(5):579-91.
10. Li MO, Flavell RA. TGF-β: a master of all T cell trades. Cell 2008; 134:392-404.
11. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation ex vivo of TGF-β-producing regulatory T cells from CD4+CD25- precursors. J Immunol. 2002;169(8):4183-9.
12. Letterio JJ. TGF-β signaling in T cells: roles in lymphoid and epithelial neoplasia. Oncogene. 2005;24(37):5701-12.
13. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor β. J Exp Med. 2001;194(5):629-44.
14. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-β in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983;258(11):7155-60.
15. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 1985;316(6030):701-5.
16. Perlman D, Halvorson HO. A putative signal peptidase recognition site and sequence in eukaryotic and prokaryotic signal peptides. J Mol Biol. 1983;167(2):391-409.
17. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-β1 gene: association with transforming growth factor-β1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66(8):1014-20.
18. Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta. 2002;316(1-2):83-94.
19. Mak JC, Leung HC, Sham AS, Mok TY, Poon YN, Ling SO, et al. Genetic polymorphisms and plasma levels of transforming growth factor-β(1) in Chinese patients with tuberculosis in Hong Kong. Cytokine. 2007;40(3):177-82.
20. Ziv E, Cauley J, Morin PA, Saiz R, Browner WS. Association between the T29 - >C polymorphism in the transforming growth factor β1 gene and breast cancer among elderly white women: the Study of Osteoporotic Fractures. JAMA. 2001; 285(22):2859-63.
21. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, et al. A transforming growth factor β1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res. 2003;63(10):2610-5.
22. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, et al. Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res. 1998;13(10):1569-76.
23. Berndt SI, Huang WY, Chatterjee N, Yeager M, Welch R, Chanock SJ, et al. Transforming growth factor β 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis. 2007; 28(9):1965-70.
24. Nikolova PN, Ivanova MI, Mihailova SM, Myhailova AP, Baltadjieva DN, Simeonov PL, et al. Cytokine gene polymorphism in kidney transplantation-impact of TGF-β 1, TNF-α and IL-6 on graft outcome. Transpl Immunol. 2008;18(4):344-8.
25. Hattori H, Matsuzaki A, Suminoe A, Ihara K, Nagatoshi Y, Sakata N, et al. Polymorphisms of transforming growth factor-β1 and transforming growth factor-β1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation. Bone Marrow Transplant. 2002;30(10):665-71.
26. Leffell MS, Vogelsang GB, Lucas DP, Delaney NL, Zachary AA. Association between TGF-β expression and severe GVHD in allogeneic bone marrow transplantation. Transplant Proc. 2001;33(1-2):485-6.
27. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
28. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β 1 gene polymorphisms. Transpl Immunol. 1999;7(2):127-8.
29. Amani D, Farjadian S, Ghaderi A. The frequency of transforming growth factor-β1 gene polymorphisms in a normal southern Iranian population. Int J Immunogenet. 2008;35(2):145-51.
30. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFβ activation. J Cell Sci. 2003;116(Pt 2):217-24.
31. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. Processing of transforming growth factor β 1 precursor by human furin convertase. J Biol Chem. 1995;270(18):10618-24.
32. Derynck R, Jarrett JA, Chen EY, Goeddel DV. The murine transforming growth factor-β precursor. J Biol Chem. 1986;261(10):4377-9.
33. Savage ND, de Boer T, Walburg KV, Joosten SA, van Meijgaarden K, Geluk A, et al. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFβ-1. J Immunol. 2008;181(3):2220-6.
34. Pihusch V, Pihusch M, Penovici M, Kolb HJ, Hiller E, Pihusch R. Transforming growth factor β-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation. Thromb Res. 2005;116(3):233-40.
35. Baron C, Somogyi R, Greller LD, Rineau V, Wilkinson P, Cho CR, et al. Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med. 2007;4(1):e23.
36. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29 - >C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation. 2000;101(24):2783-7.
37. Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112(5):1557-69.